Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00333333 · ClinicalTrials.gov registry record
Mechanism of Thrombocytopenia in Infants
A clinical trial, sponsored by Christiana Care Health Services.
- Completed
- Registry status
- 30
- Enrollment target
NCT00333333: Completed study, sponsored by Christiana Care Health Services.
NCT00333333 is a clinical trial that has completed, run by Christiana Care Health Services. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00333333 has completed, sponsored by Christiana Care Health Services.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
This research project is studying the causes for low platelet levels in preterm infants. Platelets are a component of blood that helps with clotting. The purpose of this study is to determine whether the cause for low platelet levels is the same in infants who are born to mothers with preeclampsia and infants who are small for gestational age.
Interventions
- PROCEDURE Cord blood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2006-06 |
| Est. Completion | 2008-06 |
What the finished NCT00333333 record still lists
NCT00333333 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Cord blood is the first listed.
NCT00333333 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00333333 about?
NCT00333333 is a clinical study titled "Mechanism of Thrombocytopenia in Infants". This research project is studying the causes for low platelet levels in preterm infants. Platelets are a component of blood that helps with clotting. The purpose of this study is to determine whether the cause for low platelet levels is the same in infants who are born to mothers with preeclampsia a...
What is the current status of trial NCT00333333?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2006-06. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00333333?
The interventions under investigation include: Cord blood (PROCEDURE).
Who is sponsoring clinical trial NCT00333333?
This trial is sponsored by Christiana Care Health Services, which has 82 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia